SolarCity Corporation (SCTY) has a lot more to add to today's advance of more than 4% according to Baird. The broker upgraded SolarCity to an "Outperform" from a "Neutral" rating. Analyst Ben Kallo upped his price-target to $70 from $50, which is potential upside of 24.4% to target as we type.
SolarCity engages in the design, installation, and sale or lease of solar energy systems to residential and commercial customers, and government entities in the United States. SCTY installs solar panels at minimal or no cost to customers who agree to purchase the energy from SCTY.
Kallo likes that SCTY was able to raise money with a debt offering backed by revenue from rooftop solar projects. Bloomberg New Energy Finance analyst Stefan Linder says, "This is really the first time we've seen asset-backed financing for a distributed-solar company." The green-tech company raised $54.4 million.
Hot India Companies For 2015: ATMI Inc.(ATMI)
ATMI, Inc. supplies high performance materials, materials packaging, and materials delivery systems for use in the manufacture of microelectronics devices worldwide. The company primarily offers front-end semiconductor performance materials; sub-atmospheric pressure gas delivery systems for safe handling and delivery of toxic and hazardous gases to semiconductor process equipment; and high-purity materials packaging and dispensing systems that allow for the reliable introduction of low volatility liquids and solids to microelectronics and biopharmaceutical processes. It also provides containment, mixing, and bioreactor technologies to the biotechnology, laboratory, and cell therapy markets. The company serves semiconductor and flat-panel display manufacturers, as well as the life sciences industry. It has strategic alliances with Enthone, Inc. and Lake LED Materials, Co., Ltd. The company was founded in 1986 and is headquartered in Danbury, Connecticut.
Advisors' Opinion:- [By Vanina Egea]
ATMI Inc. (ATMI)
Gabelli reported a stake of 1,193,900 shares of ATMI Inc., sized at 0.22% of his portfolio, and 3.75% of the company. It has a market cap of $1.08 billion; its shares are trading at $34.04 with a P/E ratio of 28.6 and P/S ratio of 2.77.
- [By Ben Axler]
In the table below, we've listed a sample of small-cap semiconductor capital equipment stocks such as Entegris (ENTG), Advanced Energy Industries (AEIS), ATMI Inc. (ATMI), MKS Instruments (MKSI), Photronics Inc. (PLAB), Rudolph Technologies (RTEC),FormFactor (FORM) and Mattson Technology (MTSN). The peers trade at approximately 1.0x and 15.5x 2014E revenues and EPS, respectively. Furthermore, the average peer trades at 2.1x tangible book value. However, these multiples are based on average 2014E industry revenue and earnings growth of 18% and 119%, respectively. Axcelis is poised to grow at a rate substantially above the industry average.
- [By Seth Jayson]
ATMI (Nasdaq: ATMI ) reported earnings on July 24. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended June 30 (Q2), ATMI missed estimates on revenues and missed estimates on earnings per share.
Hot Tech Stocks To Buy For 2014: CDW Corp (CDW)
CDW Corporation (CDW), incorporated on May 25, 2007, is a provider of integrated information technology (IT) solutions in the United States and Canada. Its range of offerings range from discrete hardware and software products to integrated IT solutions, such as mobility, security, data center optimization, cloud computing, virtualization and collaboration. The Company has two segments: Corporate and Public. Corporate segment consists of primarily of private sector business customers. Public segment consists of government agencies and education and healthcare institutions. CDW also has two other operating segments, CDW Advanced Services and Canada (combined together as Other). The Company is a sales channel partner for many original equipment manufacturers (OEMs) and software publishers (collectively, its vendor partners), whose products it sells or include in the solutions CDW offers. The Company helps its customer base of more than 250,000 small, medium and large business, government, education and healthcare customers by delivering solutions to their IT needs.
The Company�� Corporate segment is divided into a medium-large business customer channel, primarily serving customers with more than 100 employees, and a small business customer channel, primarily serving customers with up to 100 employees. The CDW Advanced Services business consists primarily of customized engineering services delivered by technology specialists and engineers and managed services that include infrastructure as a service (IaaS) offerings. The Company�� product portfolio includes more than 100,000 products from more than 1,000 brands. Revenues from the sale of hardware, software, custom configuration and third-party provided services are recorded within its Corporate and Public segments.
The Company�� revenue from professional services is either recognized as incurred for services billed at an hourly rate or recognized using a proportional performance model for services provided at a fixed fee.! Revenue from software as a service (SaaS) arrangements, IaaS arrangements, and data center services, including Internet connectivity, Web hosting, server co-location and managed services, is recognized over the period service is provided. The Company also sells certain products for which it acts as an agent. Products in this category include the sale of third-party services, warranties or software assurance (SA) or third-party-hosted SaaS and IaaS arrangements. The Company offer over 1,000 brands, from companies, such as APC, Apple, Cisco, EMC, Hewlett-Packard, IBM, Lenovo, Microsoft, NetApp, Symantec and VMware, to vendor partners, such as Drobo, Fusion-io, Meraki, Nimble Storage, Salesforce.com, Sophos and Splunk.
The Company competes with Dimension Data, ePlus, Insight Enterprises, PC Connection, PCM, Presidio, Softchoice, World Wide Technology, Dell, Hewlett-Packard, Apple, Amazon, Newegg, TigerDirect.com, Buy.com, IBM, Accenture, Staples, Office Depot and Office Max.
Advisors' Opinion:- [By Rich Smith]
Just over six years after leaving the public stock markets in a $7.3 billion leveraged buyout, IT equipment supplier CDW (NASDAQ: CDW ) is back on the Nasdaq again!
Hot Tech Stocks To Buy For 2014: Neurocrine Biosciences Inc.(NBIX)
Neurocrine Biosciences, Inc. engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. It develops drugs for endometriosis, stress-related disorders, pain, tardive dyskinesia, uterine fibroids, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. The company?s products in clinical development include Elagolix, a Phase II drug for endometriosis; Vesicular Monoamine Transporter 2 Inhibitor (VMAT2), a Phase II drug for movement disorders; CRF2 Peptide Agonist, a Phase II drug for cardiovascular diseases; CRF1 Antagonist, a Phase II drug for stress-related disorders; and Elagolix, a Phase II drug for uterine fibroids. Its research programs comprise G Protein-Coupled Receptor 119 (GPR119) for type II diabetes; VMAT2 for schizophrenia; GnRH Antagonists for men?s and women?s health, and oncology; Antiepileptic Drugs for epilepsy, essential tremor, and pain; and G Protein-Coupled Receptors for other conditions. The company has collaborations with GlaxoSmithKline to develop and commercialize CRF antagonists for psychiatric, neurological, and gastrointestinal diseases; Dainippon Sumitomo Pharma Co. Ltd. to develop and commercialize Indiplon in Japan; Abbott International Luxembourg S.�r.l. to develop and commercialize elagolix and GnRH antagonists for women?s and men?s health indications; and Boehringer Ingelheim International GmbH to research, develop, and commercialize small molecule GPR119 agonists for the treatment of type II diabetes and other indications. Neurocrine Biosciences, Inc. was founded in 1992 and is headquartered in San Diego, California.
Advisors' Opinion:- [By John Udovich]
Yesterday, small cap biopharmaceutical stock Neurocrine Biosciences, Inc (NASDAQ: NBIX) surged 89.69% after announcing positive results for its VMAT2 inhibitor NBI-98854 as a treatment for tardive dyskinesia, meaning investors late to the party or those already in should take a closer look at the stock along with its performance verses that of biotech ETFs like the iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and SPDR S&P Biotech ETF (NYSEARCA: XBI).
Hot Tech Stocks To Buy For 2014: Market Leader Inc(LEDR)
Market Leader, Inc., together with its subsidiaries, provides software-as-a-service-based business and marketing solutions for real estate professionals primarily in the United States and Canada. It offers real estate agents and brokerage companies with software-as-a-service based products, as well as online lead-generation, online prospect management, online real estate portal content and advertising, and customer coaching and training solutions. The company also offers consumers with free access to the information and tools they need throughout the home buying and selling process through its national consumer real estate sites. Its consumer Web sites include: JustListed.com, a service that notifies home buyers as soon as new homes hit the market; HouseValues.com, a service, which provides home sellers with market valuations of their current homes; and HomePages.com, a real estate portal that enables consumers to see the home listings in their area, view detailed neighbor hood and school data, compare recent home sales, find local real estate agents, and find the value of their own homes. In addition, the company offers Growth Leader, a Website and customer relationship management tool for real estate agents; RealtyGenerator, a lead-generation and lead management system for real estate brokerage offices; and ActiveRain.com that provides professional networking, referral, recruitment, content syndication, and online marketing services for professionals in real estate and related businesses. Market Leader, Inc. markets its products to individual agents and brokerage offices directly, as well as through marketing partnerships with real estate franchise networks. The company was formerly known as Housevalues, Inc. and changed its name to Market Leader, Inc. in November 2008. Market Leader, Inc. was founded in 1999 and is headquartered in Kirkland, Washington.
Advisors' Opinion:- [By Michael Lewis]
For a bit of context, competitor Trulia (NYSE: TRLA ) is in negotiations to buy Market Leader (NASDAQ: LEDR ) for $355�million. Market Leader is a smaller (and growing) business that's similar to both Zillow and Trulia. Since Market Leader is still earnings negative, we can't compare it on a P/FCF basis, but we can look at other metrics. For one, Market Leader trades at a still-ridiculous-but-slightly less-so 57.2 times forward earnings. It trades at 6.4 times last year's sales. Zillow trades at 16.4 times last year's sales. Management expects sales to hit (on the high end) $182 million -- that implies a price of 10.55 times forward sales. If they double a year or two after, which would be unbelievably phenomenal, it would trade at 5.3 times sales.
No comments:
Post a Comment